$32.76
Today
as of Jul 22, 16:53 ET
Last 30 days
Recent Press Releases & News
Pulse Biosciences Schedules Second Quarter 2026 Financial Results Conference Call for August 6, 2026
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pulse Biosciences to Redeem Remaining Warrants From July 2024 Offering
Overview
52-week range
$13
$28
100% of range
Avg surprise (last 2)
+4.0%
Avg reaction (last 2)
-1.4%
50% positive
Latest IV / EM
75%
EM ±17.2% · $33 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 4, 2026 | Mar/2026 | $-0.27 | $-0.32 | +15.6% | -8.0% | -3.8% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.28 | $-0.26 | -7.7% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.25 | — | — | — | +1.0% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.31 | -$0.28 | -10.7% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $370,000 | — | $279,000 | — | $0 | — | $0 | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-19M | — | $-20M | $-20M | $-18M | — | $-14M | $-12M |
| Net income | $-19M | — | $-19M | $-19M | $-17M | — | $-13M | $-11M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $68M | $81M | $95M | $106M | $119M | $118M | $79M | $26M |
| Inventory | $206,000 | $136,000 | $57,000 | $51,000 | $30,000 | $0 | — | — |
| Total current assets | $71M | $83M | $97M | $108M | $121M | $119M | $80M | $27M |
| Total assets | $82M | $95M | $109M | $120M | $133M | $132M | $93M | $40M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $15M | $14M | $16M | $16M | $15M | $18M | $14M | $13M |
| Total equity | $66M | $81M | $93M | $104M | $118M | $115M | $79M | $27M |